- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07754071
Clinical Validation of an Artificial Intelligence System for De-termining Fetal Lie and Position in 3rd Trimester
Clinical Validation of an Artificial Intelligence System for Determining Fetal Lie and Position in 3rd Trimester
Studieoversikt
Status
Detaljert beskrivelse
Accurate assessment of fetal lie and presentation during the third trimester is essential for obstetric management and delivery planning. Ultrasound is the gold standard for determining fetal orientation; however, the examination is highly operator-dependent and requires considerable experience to correctly identify fetal anatomy and orientation. Artificial intelligence (AI)-based navigational support systems have the potential to assist clinicians by providing real-time guidance during ultrasound examinations and improving the consistency of fetal orientation assessment.
The purpose of this study is to prospectively validate an AI-based navigational support system for determining fetal lie and presentation during routine third-trimester ultrasound examinations. The system analyzes blind ultrasound sweeps acquired along the maternal midline and automatically predicts fetal lie and presentation. AI-generated predictions will be compared with expert clinician assessment, which serves as the reference standard.
Eligible pregnant women attending third-trimester ultrasound examinations at the Fetal Medicine Department, Rigshospitalet, Slagelse - or Hillerød hospital, will be invited to participate. Following written informed consent, an expert clinician will first determine fetal lie and presentation as part of the routine ultrasound examination. The same clinician will subsequently acquire three blind ultrasound sweeps along the maternal midline. The AI navigational support system will analyze each sweep and generate predictions of fetal lie and presentation. All examinations will be completed within 5-10 minutes to minimize changes in fetal orientation between the clinical assessment and AI evaluation.
The primary objective is to evaluate the diagnostic performance of the AI system by comparing AI-generated predictions with expert clinician assessment. Primary outcome measures include overall diagnostic accuracy and agreement,
These findings will provide additional insight into the feasibility of implementing AI-assisted navigational support in routine obstetric ultrasound practice.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Mary Le Ngo, MD, MD
- Telefonnummer: +45 20773779
- E-post: mary.van.anh.le.ngo.01@regionh.dk
Studiesteder
-
-
-
Slagelse, Danmark, 3450
- Har ikke rekruttert ennå
- Slagelse Hospital, Department of Obstetrics and Gynecology
-
Ta kontakt med:
- Kathinka Nyborg, MD
- Telefonnummer: 20773779
- E-post: kany@regionsjaelland.dk
-
-
Capital Region
-
Hillerød, Capital Region, Danmark, 3400
- Har ikke rekruttert ennå
- Nordsjællands Hospital, Department of Obstetrics and Gynecology
-
Ta kontakt med:
- Gitte Hedermann, Associate Professor
- Telefonnummer: +2520773779
- E-post: gitte.hedermann.christensen@regionh.dk
-
-
København Ø
-
Copenhagen, København Ø, Danmark, 2100
- Rekruttering
- Rigshospitalet - Department of Obstetrics and Gynecology
-
Ta kontakt med:
- Martin Tolsgaard, professor,, Medical doctor, Ph.D
- Telefonnummer: +4520773779
- E-post: martin.groennebaek.tolsgaard@regionh.dk
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Pregnant women aged ≥18 years.
- Singleton pregnancy.
- Gestational age ≥28+0 weeks.
- Fetus in longitudinal lie (cephalic or breech presentation) as determined by the routine clinical ultrasound examination.
- Able to understand Danish or English.
- Able and willing to provide written informed consent.
Exclusion Criteria:
- Multiple pregnancy.
- Fetus in transverse lie.
- Inability to provide written informed consent.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Prospective Clinical Validation Cohort
Pregnant women with singleton pregnancies in the third trimester (≥28+0 weeks' gestation) undergoing obstetric ultrasound examination.
Participants undergo three blind ultrasound sweeps, and AI-generated predictions of fetal lie and presentation are compared with expert clinician assessment.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Diagnostic accuracy of the AI navigational support system for determining fetal lie and presentation.
Tidsramme: During the study ultrasound examination (approximately 5 minutes).
|
Overall proportion of correct AI predictions of fetal lie and presentation compared with expert clinician assessment (reference standard).
|
During the study ultrasound examination (approximately 5 minutes).
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Agreement between AI predictions and expert clinician assessment.
Tidsramme: During the study ultrasound examination.
|
Agreement will be evaluated using Cohen's kappa coefficient.
|
During the study ultrasound examination.
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- P-2019-3101
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .